cetylpyridinium chloride anhydrous and quinoxalines

cetylpyridinium chloride anhydrous has been researched along with quinoxalines in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Burstein, AH; Clark, DJ; Faessel, HM; Gibbs, MA; Gobey, JS; Smith, BJ	1
Schunack, W	1

Reviews

1 review(s) available for cetylpyridinium chloride anhydrous and quinoxalines

Article	Year
[Not smoking, essential for healthy lungs]. Pharmazie in unserer Zeit, 2008, Volume: 37, Issue:6 Topics: Administration, Cutaneous; Benzazepines; Bupropion; Chewing Gum; Health; Humans; Lung; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Tablets; Varenicline	2008

Trials

1 trial(s) available for cetylpyridinium chloride anhydrous and quinoxalines

Article	Year
Single-dose pharmacokinetics of varenicline, a selective nicotinic receptor partial agonist, in healthy smokers and nonsmokers. Journal of clinical pharmacology, 2006, Volume: 46, Issue:9 Topics: Administration, Oral; Adolescent; Adult; Benzazepines; Dose-Response Relationship, Drug; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Health; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking; Varenicline	2006

Article

Year

Single-dose pharmacokinetics of varenicline, a selective nicotinic receptor partial agonist, in healthy smokers and nonsmokers.

Journal of clinical pharmacology, 2006, Volume: 46, Issue:9

Topics: Administration, Oral; Adolescent; Adult; Benzazepines; Dose-Response Relationship, Drug; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Health; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking; Varenicline

2006